[JNJ]

Mid 2026-08-29 06:13:15

J&J's Stelara granted approval for pediatric ulcerative colitis

Mid 2026-08-29 03:57:20

J&J granted China nod for oral psoriasis pill developed with Protagonist

Mid 2026-08-25 20:08:11

J&J wins FDA label expansion for Imaavy in wAIHA

Mid 2026-07-30 22:13:35

J&J granted FDA priority review for Rybrevant Faspro in head and neck cancer

Mid 2026-07-30 06:54:33

Johnson & Johnson gets $2.58B option to acquire Sail in vivo CAR-T therapies push